Abu-Rustum N, et al. Uterine Neoplasms, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2023;21(2):181–209.
Article CAS PubMed Google Scholar
Amalric A, et al. Quantifying RNA modifications by mass spectrometry: a novel source of biomarkers in oncology. Crit Rev Clin Lab Sci. 2022;59(1):1–18.
Article CAS PubMed Google Scholar
Amort T, Lusser A. Detection of 5-methylcytosine in specific poly(A) RNAs by bisulfite sequencing. Methods Mol Biol. 2017;1562:107–21.
Article CAS PubMed Google Scholar
Amort T, et al. Transcriptome-wide detection of 5-methylcytosine by bisulfite sequencing. Methods Mol Biol. 2017;1562:123–42.
Article CAS PubMed Google Scholar
An Y, Duan H. The role of m6A RNA methylation in cancer metabolism. Mol Cancer. 2022;21(1):14.
Article CAS PubMed PubMed Central Google Scholar
Bao G, et al. Comprehensive analysis of the function, immune profiles, and clinical implication of m1A regulators in lung adenocarcinoma. Front Oncol. 2022;12:882292.
Article CAS PubMed PubMed Central Google Scholar
Bao Y, et al. Targeting m(6)A reader YTHDF1 augments antitumour immunity and boosts anti-PD-1 efficacy in colorectal cancer. Gut. 2023;72(8):1497–509.
Article CAS PubMed Google Scholar
Barbieri I, Kouzarides T. Role of RNA modifications in cancer. Nat Rev Cancer. 2020;20(6):303–22.
Article CAS PubMed Google Scholar
Bedell SL, et al. Cervical cancer screening: past, present, and future. Sex Med Rev. 2020;8(1):28–37.
Bhatla N, Singhal S. Primary HPV screening for cervical cancer. Best Pract Res Clin Obstet Gynaecol. 2020;65:98–108.
Bi X, et al. METTL3-mediated maturation of miR-126-5p promotes ovarian cancer progression via PTEN-mediated PI3K/Akt/mTOR pathway. Cancer Gene Ther. 2021;28(3–4):335–49.
Article CAS PubMed Google Scholar
Borgeaud M, et al. Immunotherapy in Urological, Gynecological and Gastrointestinal Cancers - Current Landscape. Praxis (Bern 1994). 2023;112(3):149–55.
Bray F, et al. Geographic and temporal variations in the incidence of vulvar and vaginal cancers. Int J Cancer. 2020;147(10):2764–71.
Article CAS PubMed Google Scholar
Buchanan TR, Graybill WS, Pierce JY. Morbidity and mortality of vulvar and vaginal cancers: Impact of 2-, 4-, and 9-valent HPV vaccines. Hum Vaccin Immunother. 2016;12(6):1352–6.
Article PubMed PubMed Central Google Scholar
Burd EM. Human papillomavirus and cervical cancer. Clin Microbiol Rev. 2003;16(1):1–17.
Article CAS PubMed PubMed Central Google Scholar
Burki TK. CA-125 blood test in early detection of ovarian cancer. Lancet Oncol. 2015;16(6):e269.
Buskwofie A, David-West G, Clare CA. A review of cervical cancer: incidence and disparities. J Natl Med Assoc. 2020;112(2):229–32.
Cayir A. RNA modifications as emerging therapeutic targets. Wiley Interdiscip Rev RNA. 2022;13(4):e1702.
Article CAS PubMed Google Scholar
Chantziantoniou N, et al. Inception and development of the papanicolaou stain method. Acta Cytol. 2017;61(4–5):266–80.
Article CAS PubMed Google Scholar
Chelmow D, et al. Executive summary of the uterine cancer evidence review conference. Obstet Gynecol. 2022;139(4):626–43.
PubMed PubMed Central Google Scholar
Chen SJ, et al. Epigenetically upregulated NSUN2 confers ferroptosis resistance in endometrial cancer via m(5)C modification of SLC7A11 mRNA. Redox Biol. 2024;69:102975.
Article CAS PubMed Google Scholar
Cheng J, et al. piR-823, a novel non-coding small RNA, demonstrates in vitro and in vivo tumor suppressive activity in human gastric cancer cells. Cancer Lett. 2012;315(1):12–7.
Article CAS PubMed Google Scholar
Chevalier RM. Gynecological cancer. Gynecol Prat. 1954;5(3–4):215–25 contd.
Chrysostomou AC, Kostrikis LG. Methodologies of primary HPV testing currently applied for cervical cancer screening. Life (Basel). 2020;10(11):290.
Clark KD, Rubakhin SS, Sweedler JV. Characterizing RNA modifications in single neurons using mass spectrometry. J Vis Exp. 2022;(182):10.3791/63940.
Dai X, et al. Identification of YTH domain-containing proteins as the readers for N1-methyladenosine in RNA. Anal Chem. 2018;90(11):6380–4.
Article CAS PubMed PubMed Central Google Scholar
Dochez V, et al. Biomarkers and algorithms for diagnosis of ovarian cancer: CA125, HE4, RMI and ROMA, a review. J Ovarian Res. 2019;12(1):28.
Article PubMed PubMed Central Google Scholar
Fadare O, et al. Expression of the oncofetal protein IGF2BP3 in endometrial clear cell carcinoma: assessment of frequency and significance. Hum Pathol. 2013;44(8):1508–15.
Article CAS PubMed PubMed Central Google Scholar
Fang X, et al. Role of m(5) C RNA methylation regulators in colorectal cancer prognosis and immune microenvironment. J Clin Lab Anal. 2022;36(4):e24303.
Article CAS PubMed PubMed Central Google Scholar
Feng Y, et al. Gene signatures and prognostic value of m6A RNA methylation regulators in uterine corpus endometrial carcinoma. Discov Med. 2021;31(164):111–20.
Funston G, et al. CA125 test result, test-to-diagnosis interval, and stage in ovarian cancer at diagnosis: a retrospective cohort study using electronic health records. Br J Gen Pract. 2021;71(707):e465–72.
Article PubMed PubMed Central Google Scholar
Gaffney DK, et al. Consensus recommendations for radiation therapy contouring and treatment of vulvar carcinoma. Int J Radiat Oncol Biol Phys. 2016;95(4):1191–200.
Article PubMed PubMed Central Google Scholar
Ghaemmaghami F, Akhavan S. Is postoperative CA125 level in patients with epithelial ovarian cancer reliable to guess the optimality of surgery? Eur J Gynaecol Oncol. 2011;32(2):192–5.
Gholiof M, Adamson-De Luca E, Wessels JM. The female reproductive tract microbiotas, inflammation, and gynecological conditions. Front Reprod Health. 2022;4:963752.
Article PubMed PubMed Central Google Scholar
Giessing AM, Kirpekar F. Mass spectrometry in the biology of RNA and its modifications. J Proteomics. 2012;75(12):3434–49.
Article CAS PubMed Google Scholar
Goodman A. HPV testing as a screen for cervical cancer. BMJ. 2015;350:h2372.
留言 (0)